We will be participating in HLTH Europe 2024, a premier event connecting global leaders in the healthcare ecosystem through innovative ideas and impactful initiatives. We look forward to sharing more on TMC and the U.S. healthcare market. Read the full blog here: https://lnkd.in/ezAxMbai
Texas Medical Center’s Post
More Relevant Posts
-
HLTH Europe! What an event! We’ll be sharing our key takeaways from Europe’s hottest healthcare conference next week, but in the meantime, we want to thank all those who stopped by our booth to speak to the team. We’ve gained insights into healthcare challenges and potential improvements, and it was great to hear many success stories, too! These allow us to grow as a team, as a company, and as a community and to make a real difference in the future of healthcare delivery. What were your top #HTLHEurope moments? Drop them in the comments 👇 #hlth #healthcareinnovation #healthcareai
Thanks to everyone we met at HLTH Europe!
To view or add a comment, sign in
-
PHA Conference 2023: ‘The Three-Legged Stool Innovation Integration & Technology’ Today's PHA Conference 2023 was a landmark event, highlighted by An Taoiseach, Leo Varadkar, TD's insightful address in the middle of the conference. His participation was a significant moment, shedding light on healthcare policy and innovation in Ireland. The conference, themed "Innovation, Integration, and Technology," brought together leading healthcare professionals and decision-makers. Discussions throughout the day focused on integrating these key aspects to enhance the healthcare system's efficiency and effectiveness. From the enlightening panel discussions to the expert sessions on technology and integration, each segment contributed to a deeper understanding of the challenges and opportunities in healthcare. The Private Hospitals Association is proud to have facilitated such a dynamic and informative event. #PHAconference23
To view or add a comment, sign in
-
-
📣 Three key messages that stand out from this morning: 1. Leadership & System Thinking: Effective leadership and a holistic view are crucial for navigating the complexities of modern healthcare. 🩺🔄 2. Prevention & Primary Care: Integrating prevention and health promotion into primary care is essential. 🛡️ 3. Cross-Sector Collaboration: Collaboration across sectors amplifies impact and drives meaningful change, with a focus on people. 🤝 Insightful panel lead by Eva McLellan, Roche with Minister of Health Valentina Prevolnik Rupel, Francesca Colombo, OEDC , Dr. Philipp Rösler, Concessor AG and Nora Colton, UCL Global Business School for Health #HealthcareLeadership #SystemThinking #Collaboration #Innovation #healthinnovation
Leadership in Healthcare Amidst New Technologies: Challenges, Opportunities and Solutions: We invite you to watch a live broadcast of the international healthcare conference Leadership in Healthcare Amidst New Technologies: Challenges, Opportunities and Solutions on our LinkedIn page today. Live stream starts at 09:30 CET and will last until 11:30. Stay tuned!
www.linkedin.com
To view or add a comment, sign in
-
Healthcare has been one of the slowest industries to make the shift to a self-service digital economy despite the undoubted public benefit of enhancing access and reducing costs. This isn’t just due to the hands-on nature of care and the complexities of healthcare data. It’s also an artifact of arcane financing mechanisms that pit the interests of providers, patients, and payers against one another. Hence the efforts of the US government to employ its regulatory levers to create a tipping point for #digitalhealth. In my most recent HLTH blog post, I explore why the recent CMS #Interoperability and Prior Authorization Final Rule has the potential to be that tipping point, at least in the #healthplan space.
Unlock the power of regulated interoperability and its impact on making digital health available to all. Join Kathleen Aller, Director of Healthcare Market Strategy at InterSystems, as she shares her expertise in this enlightening article. Read the article now for valuable insights: https://lnkd.in/e8nTstjX #RegulatedInteroperability #DigitalHealth #HealthcareRevolution
To view or add a comment, sign in
-
Most countries have been slow to adopt new healthcare trends and digital health, but as Kathleen Aller explains, there will eventually be a tipping point where technology and interoperability is embraced for the benefits to all!
Unlock the power of regulated interoperability and its impact on making digital health available to all. Join Kathleen Aller, Director of Healthcare Market Strategy at InterSystems, as she shares her expertise in this enlightening article. Read the article now for valuable insights: https://lnkd.in/e8nTstjX #RegulatedInteroperability #DigitalHealth #HealthcareRevolution
HLTH | The Healthcare Ecosystem Platform - HLTH
hlth.com
To view or add a comment, sign in
-
Today we will be hosting our virtual Healthcare Insights Summit 2024. At this summit, we will unpack key developments and insights in the healthcare industry and how these impact the open scheme market, focusing on Momentum Medical Scheme and Momentum Health4Me. #MoreHealth
To view or add a comment, sign in
-
-
As we wrap the HLTH 2023 conference this year, we want to keep the conversation moving. Read more from Daniel Perez, our CEO and Co-founder who expands on a key perspective: How people use technology is going to transform health care. While other industries have seen cost reductions with tech, why hasn't healthcare? Dive into the challenges, solutions, and the champions driving change in Dan's full piece on the HLTH Blog. https://lnkd.in/e33Gkpna #HingeHealth #DigitalHealthTransformation #HLTH
HLTH | The Healthcare Ecosystem Platform - HLTH
hlth.com
To view or add a comment, sign in
-
Curious about what the new year holds for the Healthcare industry in Poland and the role of Fujifilm Healthcare Europe in it? If yes, I kindly encourage you tu get acquainted with the perspective on the industry and polish market unfold by Pawel Augustyn, MD, President Central Eastern Europe at Fujifilm Healthcare Europe on Executive Forecast - multi-national platform for executive thought leadership. From the impact of Poland's resilient economy to the establishment of Fujifilm Healthcare Europe and the advancements in diagnostic imaging. Ready to be inspired? 👉 Click here to read the full interview: https://lnkd.in/d4FdNWZR #ProudlyByYourSide #FujifilmHealthcare #IndustryInsights
I had the opportunity to meet with Pawel Augustyn, MD, President Central Eastern Europe at Fujifilm Healthcare Europe, in the context of our Executive Forecast: Poland's Roadmap to Sustainable Healthcare report. Our discussion shed light on Fujifilm Healthcare's pivotal role in advancing healthcare solutions in Poland. "We firmly feel that diagnostics play a critical role in the entire process, from detection to treatment." As we delve into the challenges and opportunities outlined in Poland, it's evident that advanced diagnostics are integral to achieving sustainable health outcomes. Read our full interview here: https://lnkd.in/ddmkjWyd #Poland2024RoadmaptoSustainableHealthcare #HealthcareInnovation #FujifilmHealthcare #HealthcarePoland Mónica Vargas WhittleClara Grunbaum Cavanagh
To view or add a comment, sign in
-
-
Experienced conference interpreter and translator in Polish, Swedish and German. Expert at Centrum Business in Małopolska
20 May 2024, 10 am Sweden consistently ranks among the top few in global healthcare systems' efficiency and quality rankings. Despite variations among Nordic countries, their emphasis on innovation, robust public healthcare infrastructure, and a patient-centric approach positions the region as fertile ground for MedTech advancements and market opportunities.
Exploring the Swedish Digital Healthcare Ecosystem: Insights and Pathways
https://www.paih.gov.pl
To view or add a comment, sign in
-
Life Science & Technology Enthusiast | Female Tech Executive & C-Suite Leader | Digital Transformation | Go-to Market Leader | Data & AI | Board Member | ex-Google, ex-IBM, ex-PwC
So, I am back from JPM Healthcare conference in SanFran. It was a crazy week and a great experience. My 5 takeaways: (1) It is THE place to be for Pharma / Biotech partnering (2) Specifically for publicly traded organisations, presenting your company at the conference is a must to enforce your relevancy (3) The action is outside of the actual conference - majority of people don’t attend the conference but rather meet for business development, investment, or company analysis (4) Getting invited and attending the right evening receptions is even more critical than formal meetings. I had five receptions in one evening - could only make 3 of the 5 but they were worth it. (5) And MOST importantly, wear comfortable walking shoes and bring a good umbrella as you are moving between all the various hotels in central SanFran as you race to get to your next meeting. As mentioned previously, our BenevolentAI's Chairman & acting CEO, Francois Nader presented at the conference and did a fabulous job. He even mentioned my name as the Chief Revenue Officer in spearheading our way forward - quite an honour! The link to the recording is below. In my PoV it is worth 20 minutes of your time. However, if you don't have time here is my recap: We are at the intersection of Pharma & Tech and a pioneer & leader in AI-augmented drug discovery, enabled by the Benevolent Platform. We stand above our competition of AI in drug discovery as not only have we been doing it for 10 years, but we are also one of the rare platforms that has validated our approach via three ways : (1) Successful collaborations with AstraZeneca with TargetID and most recently Merck Healthcare KGaA with Chemistry. For AstraZeneca the products are in the pipeline and they're real. (2) We leveraged our indication expansion capabilities to identify Eli Lilly and Company's rheumatoid arthritis drug Olumiant (baricitinib) as a potential treatment for COVID-19, which received an emergency use authorisation from the US FDA in 2020; full approval in May 2022. (3) Our platform has generated 5 wholly owned products in a pipeline that looks like a traditional Biotech. Our lead asset BEN-8744 is an oral PDE10 inhibitor in Phase I which is a potential first-in-class option for ulcerative colitis. Our Business model offers multiple routes for value creation. In addition to our high potential R&D pipeline and our leading E2E Drug Discovery solutions mentioned above, we have a new expansion opportunity through suite of Knowledge Exploration tools that acting as a co-pilot for scientists, leverages bio-specific natural language processing (NLP) and large language models (LLM) to surface data, perform analysis, and give scientific recommendations to drive new insights and increase productivity. So, as you can see from above, this is a very exciting time for BenevolentAI and I am thrilled to be part of the journey! #JPM2024 #drugdiscovery #aidrugdiscovery #generativeai #researchanddevelopment
Recording available of BenevolentAI’s presentation at the 42nd Annual J.P.Morgan Healthcare Conference 📢 Our Chair and Acting CEO Francois Nader, MD, MBA presented at JPM 2024 last week - you can now watch the presentation on our website, visit the link below 👇 https://lnkd.in/eKNf2KZv Want to find out more? Get in touch - send an email to [email protected] or [email protected].
To view or add a comment, sign in
-